best performing mid-cap stocks in june 2020

Celldex Therapeutics (CLDX) had the highest return in June 2020 by a mid-cap US stock, returning 394.3%.

ASSETMONTH% RETURN
Celldex Therapeutics (CLDX)
June 2020
394.3%
Aura Minerals Inc Common Shares (AUGO)
June 2020
180.66%
Nio Inc Class A ADR (NIO)
June 2020
93%
Immunitybio (IBRX)
June 2020
76.95%
Youdao (DAO)
June 2020
65.93%
Resideo Technologies (REZI)
June 2020
65.53%
Baytex Energy (BTE)
June 2020
61.32%
Skeena Resources (SKE)
June 2020
60.23%
Chord Energy (CHRD)
June 2020
59.58%
Stagwell (STGW)
June 2020
58.78%
Vaxcyte  (PCVX)
June 2020
51.97%
Acadian Asset Management (AAMI)
June 2020
47.96%
Ideaya Biosciences (IDYA)
June 2020
46.49%
JOYY (JOYY)
June 2020
44.76%
Navios Maritime Partners LP Unit (NMM)
June 2020
42.79%
Bilibili (BILI)
June 2020
42.79%
Xp (XP)
June 2020
41.16%
Baldwin Insurance (BWIN)
June 2020
39.95%
Sasol (SSL)
June 2020
38.92%
GDS (GDS)
June 2020
37.82%
Transocean (RIG)
June 2020
37.59%
Peloton Interactive (PTON)
June 2020
37.22%
Alarm (ALRM)
June 2020
35.59%
Arrowhead Pharmaceuticals (ARWR)
June 2020
34.55%
Gap (GAP)
June 2020
34.54%
Mid-cap stocks are treated as having a market cap between $2B and $10B.